Neurocrine Biosciences Inc.

11/04/2024 | Press release | Distributed by Public on 11/04/2024 07:58

Neurocrine Biosciences Presents New Data on INGREZZA® (valbenazine) Capsules at Psych Congress 2024: Majority of Long-Term Study Participants Achieved Remission of Tardive[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.